The channelized-Hotelling observer (CHO) was investigated as a surrogate of human observers in task-based image quality assessment. The CHO with difference-of-Gaussian (DoG) channels has shown potential for the prediction of human detection performance in digital mammography (DM) images. However, the DoG channels employ parameters that describe the shape of each channel. The selection of these parameters influences the performance of the DoG CHO and needs further investigation. The detection performance of the DoG CHO was calculated and correlated with the detection performance of three humans who evaluated DM images in 2-alternative forced-choice experiments. A set of DM images of an anthropomorphic breast phantom with and without calcification-like signals was acquired at four different dose levels. For each dose level, 200 square regions-of-interest (ROIs) with and without signal were extracted. Signal detectability was assessed on ROI basis using the CHO with various DoG channel parameters and it was compared to that of the human observers. It was found that varying these DoG parameter values affects the correlation ( ) of the CHO with human observers for the detection task investigated. In conclusion, it appears that the the optimal DoG channel sets that maximize the prediction ability of the CHO might be dependent on the type of background and signal of ROIs investigated.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763759PMC
http://dx.doi.org/10.1117/1.JMI.6.3.035501DOI Listing

Publication Analysis

Top Keywords

human observers
12
detection performance
12
channel sets
8
dog channels
8
performance dog
8
dog cho
8
dog channel
8
cho
7
dog
7
optimization difference-of-gaussian
4

Similar Publications

Background: The novel coronavirus disease (COVID-19) sparked significant health concerns worldwide, prompting policy makers and health care experts to implement nonpharmaceutical public health interventions, such as stay-at-home orders and mask mandates, to slow the spread of the virus. While these interventions proved essential in controlling transmission, they also caused substantial economic and societal costs and should therefore be used strategically, particularly when disease activity is on the rise. In this context, geosocial media posts (posts with an explicit georeference) have been shown to provide a promising tool for anticipating moments of potential health care crises.

View Article and Find Full Text PDF

Background: Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition emerging in early childhood, characterized by core features such as sociocommunicative deficits and repetitive, rigid behaviors, interests, and activities. In addition to these, disruptive behaviors (DB), including aggression, self-injury, and severe tantrums, are frequently observed in pediatric patients with ASD. The atypical antipsychotics risperidone and aripiprazole, currently the only Food and Drug Administration-approved treatments for severe DB in patients with ASD, often encounter therapeutic failure or intolerance.

View Article and Find Full Text PDF

Background And Objectives: Patients with multiple sclerosis (MS) may demonstrate better disease control when treatment is initiated on high-efficacy disease-modifying therapies (DMTs) from onset. This subgroup analysis assessed the long-term efficacy and safety profile of the high-efficacy DMT ocrelizumab (OCR) as first-line therapy for early-stage relapsing MS (RMS).

Methods: Post hoc exploratory analyses of efficacy and safety were performed in a subgroup of treatment-naive patients with RMS who received ≥1 dose of OCR in the multicenter OPERA I/II (NCT01247324/NCT01412333) studies.

View Article and Find Full Text PDF

Background And Objectives: Mitochondrial disorders are multiorgan disorders resulting in significant morbidity and mortality. We aimed to characterize death-associated factors in an international cohort of deceased individuals with mitochondrial disorders.

Methods: This cross-sectional multicenter observational study used data provided by 26 mitochondrial disease centers from 8 countries from January 2022 to March 2023.

View Article and Find Full Text PDF

Purpose: Prior noncontemporary studies showed that oral cyclophosphamide is an active treatment of metastatic castration-resistant prostate cancer (mCRPC). However, cyclophosphamide is currently underutilized in routine clinical practice given the lack of survival benefit and the emergence of more effective treatments.

Methods: We retrospectively reviewed our institutional database to identify patients with mCRPC treated with cyclophosphamide.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!